Key Techniques and Application Progress of Molecular Pharmacognosy

被引:1
作者
XIAO XuefengHU JingXU HaiyuGAO WenyuanZHANG TiejunLIU Changxiao School of Chinese Materia MedicaTianjin University of Traditional Chinese MedicineTianjin China The National Key Laboratory of Pharmacokinetics and PharmacodynamicsTianjin Institute of Pharmaceutical ResearchTianjin China School of Pharmaceutical Science and TechnologyTianjin UniversityTianjin China Research Center of Modern Chinese MedicinesTianjin Institute of Pharmaceutical ResearchTianjin China Institute of Chinese Materia MedicaChina Academy of Chinese Medical SciencesBeijing China [1 ,1 ,2 ,5 ,3 ,4 ,2 ,1 ,300193 ,2 ,300193 ,3 ,300072 ,4 ,300193 ,5 ,100700 ]
机构
关键词
DNA marker; genetic diversity; molecular biology; molecular pharmacognosy; pharmacognosy;
D O I
暂无
中图分类号
S567 [药用作物];
学科分类号
1008 ;
摘要
At the boundary between pharmacognosy and molecular biology,molecular pharmacognosy has developed as a new borderline discipline.This paper reviews the methods,application,and prospect of molecular pharmacognosy.DNA marker is one of genetic markers and some molecular marker methods which have been successfully used for genetic diversity identification and new medicinal resources development.Recombinant DNA technology provides a powerful tool that enables scientists to engineer DNA sequences.Gene chip technique could be used in determination of gene expression profiles,analyses of polymorphisms,construction of genomic library,analysis of mapping,and sequencing by hybridization.Using the methods and theory of molecular biology and pharmacognosy,molecular pharmacognosy represents an extremely prospective branch of pharmacognosy and focuses on the study of systemic growth of medicinal plants,identification and evaluation of germplasm resources,plant metabolomics and production of active compounds.Furthermore,the great breakthrough of molecular pharmacognosy could be anticipated on DNA fingerprint analysis,cultivar improvement,DNA identification,and a global DNA barcoding system in the future.
引用
收藏
页码:106 / 116
页数:11
相关论文
共 41 条
[1]   药用植物种质资源ITS序列研究进展 [J].
于华会 ;
杨志玲 ;
杨旭 ;
谭梓峰 ;
舒枭 ;
刘若楠 .
中草药, 2010, 41 (03) :491-496
[2]   Strategies for Revitalization of Traditional Medicine [J].
MUKHERJEE Pulok K ;
PITCHAIRAJAN Venkatesh ;
MURUGAN Venkatesh ;
SIVASANKARAN Ponnusankar ;
KHAN Yaseen .
Chinese Herbal Medicines, 2010, 2 (01) :1-15+83
[3]   Challenges in Research and Development of Traditional Chinese Medicines [J].
LIU Changxiao XIAO Peigen PENG Yong SONG Naining Tianjin Institute of Pharmaceutical Research Tianjin China Institute of Medicinal Plant Development Chinese Academy of Medical Sciences Beijing China .
Chinese Herbal Medicines, 2009, 1 (01) :1-28
[4]  
转基因何首乌毛状根生物转化麝香草酚(英文)[J]. 董权锋,贾郡璋,朱建华,于荣敏.中药材. 2009(10)
[5]   丹参功能基因组学研究Ⅰ——cDNA芯片的构建 [J].
崔光红 ;
黄璐琦 ;
唐晓晶 ;
邱德有 ;
王学勇 ;
付桂芳 .
中国中药杂志, 2007, (12) :1137-1141
[6]   鄂尔多斯高原锦鸡儿属药用植物的ISSR分析 [J].
杨九艳 ;
杨劼 ;
杨明博 ;
鞠爱华 ;
渠弼 .
中草药, 2006, (10) :1562-1566
[7]   道地药材江枳壳品种遗传学关系的ISSR证据 [J].
左云娟 ;
朱培林 ;
刘强 ;
陈春华 ;
周世良 .
中国中药杂志, 2005, (18) :1416-1419
[8]   ISSR-PCR在石斛种间鉴别中的应用 [J].
沈颖 ;
徐程 ;
万小凤 ;
张铭 .
中草药, 2005, (03) :423-427
[9]   怀区地黄遗传多样性的ISSR鉴定 [J].
周延清 ;
景建洲 ;
李振勇 ;
张宝华 ;
王天亮 ;
贾敬芬 .
中草药, 2005, (02) :257-261
[10]   正品龙胆遗传多样性的RAPD及ISSR分析 [J].
曹雅男 ;
李庆章 ;
孙岳 ;
李璐 ;
王大威 ;
李景鹏 .
中草药, 2005, (01) :100-103